← Back to Analyst Consensus 
ALNY Buy
ALNYLAM PHARMACEUTICALS, INC.
Current Price —
Implied Upside —
Analysts 38
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 4 reiterations from 4 firms
Next Earnings
Oct 29, 2026 (3 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 14, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Oct 14, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Oct 8, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Sep 30, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Sep 21, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Sep 8, 2026 | Jefferies | maintain | Hold → Hold | — | 52% |
| Sep 2, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 19, 2026 | BMO Capital | initiate | Outperform → Outperform | — | 53% |
| Aug 14, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Aug 4, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Aug 4, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 3, 2026 | Raymond James | upgrade | Outperform → Strong Buy | — | 54% |
| Aug 3, 2026 | Citigroup | maintain | Buy → Buy | — | 54% |
| Aug 3, 2026 | Barclays | maintain | Overweight → Overweight | — | 53% |
| Jul 31, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 31, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| Jul 31, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 31, 2026 | Oppenheimer | maintain | Outperform → Outperform | — | 52% |
| Jul 31, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jul 31, 2026 | Stifel | maintain | Buy → Buy | — | 53% |
| Jul 31, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jul 30, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| Jul 22, 2026 | JP Morgan | maintain | Overweight → Overweight | — | 54% |
| Jul 14, 2026 | B of A Securities | maintain | Buy → Buy | — | 53% |
| Jul 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Jul 13, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jul 10, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Jun 29, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Jun 4, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 19, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| May 5, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 1, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 1, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | — | 54% |
| Apr 13, 2026 | Truist Securities | maintain | Buy → Buy | — | 54% |
| Mar 25, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Mar 25, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Mar 16, 2026 | Jefferies | downgrade | Buy → Hold | — | 52% |
| Feb 18, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | $510 | 44% |
| Feb 17, 2026 | Freedom Capital Markets | upgrade | Hold → Buy | — | 43% |
| Feb 17, 2026 | Freedom Broker | upgrade | Hold → Buy | — | 59% |
| Feb 17, 2026 | Canaccord Genuity | maintain | Buy → Buy | $429 | 48% |
| Feb 13, 2026 | Chardan Capital | maintain | Buy → Buy | $425 | 47% |
| Feb 12, 2026 | Needham | maintain | Buy → Buy | $510 | 50% |
| Jan 30, 2026 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $408 | 54% |
| Jan 30, 2026 | B of A Securities | maintain | Buy → Buy | $462 | 53% |
| Jan 30, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | $510 | 44% |
| Jan 28, 2026 | Barclays | initiate | — → Overweight | $527 | 53% |
| Jan 20, 2026 | RBC Capital | maintain | Outperform → Outperform | $465 | 55% |
| Jan 20, 2026 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $376 | 54% |
| Jan 12, 2026 | B of A Securities | maintain | Buy → Buy | $529 | 53% |
Price Target Trend
Jul 27, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days